Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-04-01 Sale |
2025-04-03 9:52 pm |
Beam Therapeutics Inc. | BEAM | Evans John M. CEO |
30,663 | $18.35 | $562,684 | 1,089,249 (Indirect Direct) |
View |
| 2025-01-30 Sale |
2025-02-03 4:05 pm |
Beam Therapeutics Inc. | BEAM | Evans John M. CEO |
30,000 | $26.75 | $802,484 | 1,166,659 (Indirect Direct) |
View |
| 2024-09-30 Sale |
2024-10-02 5:49 pm |
Beam Therapeutics Inc. | BEAM | Evans John M. CEO |
60,000 | $24.6 | $1,476,024 | 1,041,659 (Indirect Direct) |
View |
| 2024-06-27 Sale |
2024-06-28 4:15 pm |
Beam Therapeutics Inc. | BEAM | Evans John M. CEO |
60,000 | $24.5 | $1,470,156 | 1,101,343 (Indirect Direct) |
View |
| 2024-04-01 Sale |
2024-04-03 7:36 pm |
Beam Therapeutics Inc. | BEAM | Evans John M. CEO |
18,102 | $32.13 | $581,617 | 1,314,644 (Indirect Direct) |
View |
| 2024-03-28 Sale |
2024-04-01 4:10 pm |
Beam Therapeutics Inc. | BEAM | Evans John M. CEO |
60,000 | $33.86 | $2,031,402 | 1,179,445 (Indirect Direct) |
View |
| 2024-01-31 Sale |
2024-02-02 4:05 pm |
Beam Therapeutics Inc. | BEAM | Evans John M. CEO |
60,000 | $25.33 | $1,519,800 | 1,316,262 (Indirect Direct) |
View |
| 2023-04-03 Sale |
2023-04-05 8:30 pm |
Beam Therapeutics Inc. | BEAM | Evans John M. CEO |
11,654 | $29.63 | $345,334 | 1,220,979 (Indirect Direct) |
View |
| 2022-10-31 Sale |
2022-11-02 4:30 pm |
Beam Therapeutics Inc. | BEAM | Evans John M. CEO |
50,000 | $46.33 | $2,316,428 | 1,161,520 (Indirect Direct) |
View |
| 2022-07-28 Sale |
2022-07-29 4:06 pm |
Beam Therapeutics Inc. | BEAM | Evans John M. CEO |
50,000 | $65.76 | $3,288,081 | 1,211,520 (Indirect Direct) |
View |
| 2022-04-28 Sale |
2022-05-02 6:51 pm |
Beam Therapeutics Inc. | BEAM | Evans John M. CEO |
50,000 | $37.98 | $1,898,899 | 1,709,415 (Indirect Direct) |
View |
| 2022-03-31 Sale |
2022-04-04 8:27 pm |
Beam Therapeutics Inc. | BEAM | Evans John M. CEO |
6,261 | $59.11 | $370,088 | 1,252,070 (Indirect Direct) |
View |
| 2022-01-31 Sale(A) |
2022-02-02 6:00 pm |
Beam Therapeutics Inc. | BEAM | Evans John M. CEO |
50,000 | $66.84 | $3,341,903 | 2,963,840 (Indirect Direct) |
View |
| 2021-10-06 Sale |
2021-10-08 4:21 pm |
Beam Therapeutics Inc. | BEAM | Evans John M. CEO |
47,700 | $83.8 | $3,997,268 | 1,548,170 (Indirect Direct) |
View |
| 2021-08-19 Sale |
2021-08-20 6:05 pm |
Beam Therapeutics Inc. | BEAM | Evans John M. CEO |
20,000 | $99.49 | $1,989,744 | 1,595,870 (Indirect Direct) |
View |
| 2021-07-07 Sale |
2021-07-08 6:00 pm |
Beam Therapeutics Inc. | BEAM | Evans John M. CEO |
25,000 | $107.87 | $2,696,826 | 1,615,870 (Indirect Direct) |
View |
| 2021-04-21 Sale |
2021-04-23 4:45 pm |
Beam Therapeutics Inc. | BEAM | Evans John M. CEO |
25,000 | $70.49 | $1,762,216 | 1,640,774 (Indirect Direct) |
View |
| 2020-12-30 Sale |
2021-01-04 5:31 pm |
Beam Therapeutics Inc. | BEAM | Evans John M. CEO |
22,300 | $84.94 | $1,894,125 | 1,193,957 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-31 Option Award |
2025-04-02 7:10 pm |
N/A N/A |
Beam Therapeutics Inc. | BEAM | Evans John M. CEO |
77,500 | $0 | 1,119,159 (Direct) |
View |
| 2025-01-30 Exercise(A) |
2025-04-02 4:05 pm |
N/A 2028-05-08 |
Beam Therapeutics Inc. | BEAM | Evans John M. CEO |
30,000 | $0 | 1,037,995 (Direct) |
View |
| 2025-01-30 Exercise(A) |
2025-04-02 4:05 pm |
N/A N/A |
Beam Therapeutics Inc. | BEAM | Evans John M. CEO |
30,000 | $0.67 | 1,037,995 (Direct) |
View |
| 2025-01-31 Option Award |
2025-02-03 4:05 pm |
N/A 2035-01-31 |
Beam Therapeutics Inc. | BEAM | Evans John M. CEO |
155,000 | $0 | 1,166,659 (Direct) |
View |
| 2024-04-03 Option Award |
2024-04-03 7:36 pm |
2024-04-03 2028-05-08 |
Beam Therapeutics Inc. | BEAM | Evans John M. CEO |
153,301 | $0 | 1,314,644 (Direct) |
View |
| 2024-03-31 Option Award |
2024-04-01 4:10 pm |
N/A N/A |
Beam Therapeutics Inc. | BEAM | Evans John M. CEO |
77,500 | $0 | 1,179,445 (Direct) |
View |
| 2024-01-31 Option Award |
2024-02-02 4:05 pm |
N/A 2034-01-31 |
Beam Therapeutics Inc. | BEAM | Evans John M. CEO |
155,000 | $24.4 | 1,316,262 (Direct) |
View |
| 2023-03-31 Exercise |
2023-03-31 7:48 pm |
N/A N/A |
Beam Therapeutics Inc. | BEAM | Evans John M. CEO |
13,850 | $7.22 | 1,541,557 (Direct) |
View |
| 2023-03-31 Exercise |
2023-03-31 7:48 pm |
N/A 2029-05-17 |
Beam Therapeutics Inc. | BEAM | Evans John M. CEO |
13,850 | $0 | 1,541,557 (Direct) |
View |
| 2023-03-06 Acquisition |
2023-03-31 7:48 pm |
N/A N/A |
Beam Therapeutics Inc. | BEAM | Evans John M. CEO |
225 | $0 | 1,541,557 (Direct) |
View |
| 2023-01-31 Option Award |
2023-03-31 7:48 pm |
N/A 2033-01-31 |
Beam Therapeutics Inc. | BEAM | Evans John M. CEO |
168,750 | $0 | 1,541,557 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-13 5:00 pm |
N/A 2032-06-08 |
Verve Therapeutics Inc. | VERV | Evans John M. Director |
15,500 | $0 | 15,500 (Direct) |
View |
| 2022-04-28 Exercise |
2022-05-02 6:51 pm |
N/A N/A |
Beam Therapeutics Inc. | BEAM | Evans John M. CEO |
12,246 | $7.22 | 1,709,415 (Direct) |
View |
| 2022-04-28 Exercise |
2022-05-02 6:51 pm |
N/A 2029-05-17 |
Beam Therapeutics Inc. | BEAM | Evans John M. CEO |
59,450 | $0 | 1,709,415 (Direct) |
View |
| 2022-04-28 Exercise |
2022-05-02 6:51 pm |
N/A N/A |
Beam Therapeutics Inc. | BEAM | Evans John M. CEO |
47,204 | $1.03 | 1,709,415 (Direct) |
View |
| 2022-03-31 Option Award |
2022-04-04 8:27 pm |
N/A N/A |
Beam Therapeutics Inc. | BEAM | Evans John M. CEO |
56,250 | $0 | 1,252,070 (Direct) |
View |
| 2022-01-31 Exercise(A) |
2022-02-02 6:00 pm |
N/A 2028-07-13 |
Beam Therapeutics Inc. | BEAM | Evans John M. CEO |
100,000 | $0 | 2,963,840 (Direct) |
View |
| 2021-11-16 Gift(A) |
2022-02-02 6:00 pm |
N/A N/A |
Beam Therapeutics Inc. | BEAM | Evans John M. CEO |
12,000 | $0 | 2,963,840 (Direct) |
View |
| 2022-01-31 Exercise(A) |
2022-02-02 6:00 pm |
N/A N/A |
Beam Therapeutics Inc. | BEAM | Evans John M. CEO |
100,000 | $1.03 | 2,963,840 (Direct) |
View |
| 2022-01-31 Option Award(A) |
2022-02-02 6:00 pm |
N/A 2032-01-31 |
Beam Therapeutics Inc. | BEAM | Evans John M. CEO |
112,500 | $0 | 2,963,840 (Direct) |
View |
| 2021-10-06 Exercise |
2021-10-08 4:21 pm |
N/A 2028-07-13 |
Beam Therapeutics Inc. | BEAM | Evans John M. CEO |
27,700 | $0 | 1,548,170 (Direct) |
View |
| 2021-10-06 Exercise |
2021-10-08 4:21 pm |
N/A N/A |
Beam Therapeutics Inc. | BEAM | Evans John M. CEO |
27,700 | $1.03 | 1,548,170 (Direct) |
View |
| 2021-08-19 Exercise |
2021-08-20 6:05 pm |
N/A 2028-07-13 |
Beam Therapeutics Inc. | BEAM | Evans John M. CEO |
12,000 | $0 | 1,595,870 (Direct) |
View |
| 2021-08-19 Exercise |
2021-08-20 6:05 pm |
N/A N/A |
Beam Therapeutics Inc. | BEAM | Evans John M. CEO |
12,000 | $1.03 | 1,595,870 (Direct) |
View |
| 2021-07-07 Exercise |
2021-07-08 6:00 pm |
N/A 2028-07-13 |
Beam Therapeutics Inc. | BEAM | Evans John M. CEO |
25,000 | $0 | 1,615,870 (Direct) |
View |
| 2021-07-07 Exercise |
2021-07-08 6:00 pm |
N/A N/A |
Beam Therapeutics Inc. | BEAM | Evans John M. CEO |
25,000 | $1.03 | 1,615,870 (Direct) |
View |
| 2021-06-29 Other |
2021-06-30 6:00 pm |
N/A N/A |
Beam Therapeutics Inc. | BEAM | Evans John M. Chief Executive Officer |
32 | $0 | 1,244,557 (Direct) |
View |
| 2021-06-25 Acquisition |
2021-06-30 6:00 pm |
N/A N/A |
Beam Therapeutics Inc. | BEAM | Evans John M. Chief Executive Officer |
64 | $0 | 1,244,557 (Direct) |
View |
Ownership |
2021-06-16 7:37 pm |
N/A 2031-03-31 |
Verve Therapeutics Inc. | VERV | Evans John M. Director |
0 | $0 | 43,198 (Direct) |
View |
| 2021-04-23 Exercise |
2021-04-23 4:45 pm |
N/A 2028-07-13 |
Beam Therapeutics Inc. | BEAM | Evans John M. CEO |
6,000 | $0 | 1,640,774 (Direct) |
View |
| 2021-04-23 Exercise |
2021-04-23 4:45 pm |
N/A N/A |
Beam Therapeutics Inc. | BEAM | Evans John M. CEO |
6,000 | $1.03 | 1,640,774 (Direct) |
View |
| 2021-03-18 Acquisition |
2021-04-12 7:29 pm |
N/A N/A |
Beam Therapeutics Inc. | BEAM | Evans John M. Chief Executive Officer |
97 | $0 | 1,263,429 (Direct) |
View |
| 2021-03-31 Option Award |
2021-04-02 5:20 pm |
N/A 2031-03-31 |
Beam Therapeutics Inc. | BEAM | Evans John M. CEO |
208,125 | $0 | 1,402,082 (Direct) |
View |